ArticleClinical and experimental medicine2025
Mortality in isolated polymyalgia rheumatica and giant cell arteritis is not increased: evidence from cohort data.
Article in Clinical and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A recent study published in Arthritis Research and Therapy by Tengesdal et al. reported that patients with isolated polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) do not have increased all-cause mortality compared with the general population. Regarding this, we present data from our own previous investigation in northwest Spain, which also showed no increased mortality in 185 patients with PMR or 109 patients with biopsy-confirmed GCA. In this regard, in the northwest Spanish GCA group, mortality was primarily due to cardiovascular causes and was comparable to that of the general population. These findings support the conclusion that neither PMR nor GCA significantly affects life expectancy when appropriately diagnosed and treated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.